Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
7680661520012
CH-66152
Konzentrat
Associated product:
TECENTRIQ conc perf 1200 mg/20 ml flac 20 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4221.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2017
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 66152
- Drug name
- Tecentriq, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 23/05/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TECENTRIQ conc perf 1200 mg/20 ml flac 20 ml
- Description (DE)
- TECENTRIQ Inf Konz 1200 mg/20 ml Durchstf 20 ml
- Market launch
- 23/05/2017
- Narcotic (BTM)
- No
Other package sizes (1)
TECENTRIQ conc perf 840 mg/14 ml flac 14 ml
1 DUR
GTIN: 7680661520029